Omega Protein Corporation (OME) was Reiterated by Pivotal Research Group to “Buy” according to the research note released today. The brokerage firm has raised the Price Target to $ 30 from a previous price target of $25 . Pivotal Research Group advised their investors in a research report released on Aug 2, 2016.
On the company’s financial health, Omega Protein Corporation reported $0.40 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on May 4, 2016. Analyst had a consensus of $0.36. The company had revenue of $84.84 million for the quarter, compared to analysts expectations of $83.29 million. The company’s revenue was up 18.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.12 EPS.
Omega Protein Corporation opened for trading at $22.17 and hit $22.65 on the upside on Friday, eventually ending the session at $22.52, with a gain of 1.99% or 0.44 points. The heightened volatility saw the trading volume jump to 1,85,381 shares. Company has a market cap of $501 M.
In a different news, on Dec 8, 2015, Andrew Johannesen (Exec VP and CFO) sold 5,298 shares at $23.47 per share price. According to the SEC, on Nov 12, 2015, Mark Edward Griffin (President – Animal Nutrition) sold 29,561 shares at $21.83 per share price. On Aug 12, 2015, John D Held (Exec VP, General Counsel & Sec) sold 37,700 shares at $16.78 per share price, according to the Form-4 filing with the securities and exchange commission.
Omega Protein Corporation is a nutritional product company. The Company operates through two segments: animal nutrition and human nutrition. The animal nutrition segment consists primarily of two subsidiaries: Omega Protein Inc. (Omega Protein) and Omega Shipyard Inc. (Omega Shipyard). Omega Protein the principal operating subsidiary produces animal nutrition products and operates in the menhaden harvesting and processing business. Omega Shipyard owns and operates a 49.4 acre shipyard facility in Moss Point Mississippi. The human nutrition segment has three primary product lines: dairy protein products specialty oils and fatty acids and other nutraceutical ingredients. The human nutrition business consists of Nutegrity a division of the Company consisting of three subsidiaries: Cyvex Nutrition Inc. (Cyvex) InCon Processing L.L.C. (InCon) and Wisconsin Specialty Protein L.L.C. (WSP) and Bioriginal Food & Science Corp. (Bioriginal).